Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blepharo Conjunctivitis”

6 trials

Showing 6 of 6 results

Very early researchUnknownNCT03975374
What this trial is testing

To Study Efficacy and Safety of Tobradex Eye Drop Suspension vs Tobramycin/Dexamethasone Ophthalmic Suspension

Who this might be right for
Blepharo Conjunctivitis
Sutphin Drugs 5,000
Post-approval studies (Phase 4)Study completedNCT00705159
What this trial is testing

Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis

Who this might be right for
Conjunctivitis
Bausch & Lomb Incorporated 137
Not applicableLooking for participantsNCT07431385
What this trial is testing

Performance and Safety of IRIDIUM GARZE in Blepharitis or Blepharconjunctivitis Adjuvant Treatment

Who this might be right for
BlepharitisBlepharoconjunctivitis
Fidia Farmaceutici s.p.a. 80
Large-scale testing (Phase 3)WithdrawnNCT00754949
What this trial is testing

Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis

Who this might be right for
Blepharoconjunctivitis
Sun Pharmaceutical Industries Limited
Large-scale testing (Phase 3)Study completedNCT00578955
What this trial is testing

Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis

Who this might be right for
Blepharoconjunctivitis
Sun Pharmaceutical Industries Limited 417
Testing effectiveness (Phase 2)Ended earlyNCT01220258
What this trial is testing

A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641)

Who this might be right for
Posterior Blepharoconjunctivitis
Merck Sharp & Dohme LLC 29

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation